Literature DB >> 18391505

Podocyte injury induced by albumin overload in vivo and in vitro: involvement of TGF-beta and p38 MAPK.

Shigetaka Yoshida1, Miki Nagase, Shigeru Shibata, Toshiro Fujita.   

Abstract

BACKGROUND: Proteinuria is a well-established exacerbating factor in chronic kidney disease. Although the mechanisms of albumin-induced tubulointerstitial damage have been extensively studied, the influence of proteinuria on podocytes has not been sufficiently elucidated. The present study examined the effect of albumin overload on podocytes in vivo and in vitro and explored the underlying mechanisms.
METHODS: Rat podocytes were exposed to albumin overload in vivo by the intraperitoneal injection of albumin over 2 days whilst cultured podocytes were subjected to albumin in vitro. We analyzed albumin uptake, podocyte apoptosis, staining for F-actin and nephrin and involvement of TGF-beta1 and p38 MAPK cascades.
RESULTS: Rats administered albumin exhibited massive proteinuria and podocyte injury manifested by decreased nephrin immunostaining and foot process effacement. These abnormalities were accompanied by albumin deposition, TGF-beta1 upregulation, p38 MAPK phosphorylation and an increased number of glomerular TUNEL-positive cells. Exposure of cultured podocytes to albumin caused actin disarrangement and apoptosis. Podocyte injury was preceded by albumin uptake, induction of TGF-beta1 and phosphorylated p38 MAPK. Treatment of podocytes with anti-TGF-beta1 neutralizing antibody or SB203580 significantly reduced the albumin-induced injury.
CONCLUSIONS: These results indicate that albumin overload in vivo and in vitro promotes podocyte injury mainly via TGF-beta1/p38 MAPK pathways. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391505     DOI: 10.1159/000124236

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  33 in total

Review 1.  Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies.

Authors:  Sahar A Fathallah-Shaykh
Journal:  Pediatr Nephrol       Date:  2016-06-27       Impact factor: 3.714

Review 2.  The enigmatic parietal epithelial cell is finally getting noticed: a review.

Authors:  Takamoto Ohse; Jeffrey W Pippin; Alice M Chang; Ronald D Krofft; Jeffrey H Miner; Michael R Vaughan; Stuart J Shankland
Journal:  Kidney Int       Date:  2009-10-21       Impact factor: 10.612

Review 3.  Drug discovery in focal and segmental glomerulosclerosis.

Authors:  Nick Pullen; Alessia Fornoni
Journal:  Kidney Int       Date:  2016-04-23       Impact factor: 10.612

Review 4.  Role of albumin and its modifications in glomerular injury.

Authors:  Shipra Agrawal; William E Smoyer
Journal:  Pflugers Arch       Date:  2017-07-22       Impact factor: 3.657

5.  Protective effects of eplerenone on podocyte injury in adriamycin nephropathy rats.

Authors:  Zhan Fang; Chun Zhang; Fangfang He; Shan Chen; Xifeng Sun; Zhonghua Zhu; Jianshe Liu; Xianfang Meng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

6.  Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.

Authors:  Ruma Pengal; Adam J Guess; Shipra Agrawal; Joshua Manley; Richard F Ransom; Robert J Mourey; Rainer Benndorf; William E Smoyer
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-25

7.  PKC-delta promotes renal tubular cell apoptosis associated with proteinuria.

Authors:  Xiaoning Li; Navjotsingh Pabla; Qingqing Wei; Guie Dong; Robert O Messing; Cong-Yi Wang; Zheng Dong
Journal:  J Am Soc Nephrol       Date:  2010-04-15       Impact factor: 10.121

Review 8.  Childhood nephrotic syndrome--current and future therapies.

Authors:  Larry A Greenbaum; Rainer Benndorf; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

9.  Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.

Authors:  Shigetaka Yoshida; Kenichi Ishizawa; Nobuhiro Ayuzawa; Kohei Ueda; Maki Takeuchi; Wakako Kawarazaki; Toshiro Fujita; Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2013-10-24       Impact factor: 2.801

Review 10.  Update on the glomerular filtration barrier.

Authors:  George Jarad; Jeffrey H Miner
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-05       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.